Evaluation of combination therapy with Statin and Ezetimible for patients with type II diabetes.

Trial Profile

Evaluation of combination therapy with Statin and Ezetimible for patients with type II diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
  • Indications Dyslipidaemias; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Jul 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan.
    • 28 Jan 2013 Planned End Date (31 Mar 2015) added as reported by University Hospital Medical Information Network - Japan.
    • 03 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top